- Home
- PLPC vs ANAB Comparison
PLPC vs ANAB Comparison
Compare PLPC & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLPC
- ANAB
- Stock Information
- Founded
- PLPC 1947
- ANAB 2005
- Country
- PLPC United States
- ANAB United States
- Employees
- PLPC N/A
- ANAB N/A
- Industry
- PLPC Water Sewer Pipeline Comm & Power Line Construction
- ANAB Biotechnology: Pharmaceutical Preparations
- Sector
- PLPC Industrials
- ANAB Health Care
- Exchange
- PLPC Nasdaq
- ANAB Nasdaq
- Market Cap
- PLPC 671.9M
- ANAB 600.4M
- IPO Year
- PLPC N/A
- ANAB 2017
- Fundamental
- Price
- PLPC $132.59
- ANAB $19.22
- Analyst Decision
- PLPC
- ANAB Buy
- Analyst Count
- PLPC 0
- ANAB 11
- Target Price
- PLPC N/A
- ANAB $54.64
- AVG Volume (30 Days)
- PLPC 9.9K
- ANAB 622.4K
- Earning Date
- PLPC 10-30-2024
- ANAB 11-05-2024
- Dividend Yield
- PLPC 0.60%
- ANAB N/A
- EPS Growth
- PLPC N/A
- ANAB N/A
- EPS
- PLPC 6.65
- ANAB N/A
- Revenue
- PLPC $572,200,000.00
- ANAB $57,172,000.00
- Revenue This Year
- PLPC N/A
- ANAB $207.49
- Revenue Next Year
- PLPC N/A
- ANAB N/A
- P/E Ratio
- PLPC $20.17
- ANAB N/A
- Revenue Growth
- PLPC N/A
- ANAB 282.17
- 52 Week Low
- PLPC $109.01
- ANAB $13.36
- 52 Week High
- PLPC $142.91
- ANAB $41.31
- Technical
- Relative Strength Index (RSI)
- PLPC 61.87
- ANAB 27.42
- Support Level
- PLPC $135.35
- ANAB $20.81
- Resistance Level
- PLPC $142.91
- ANAB $22.94
- Average True Range (ATR)
- PLPC 3.37
- ANAB 1.58
- MACD
- PLPC 0.88
- ANAB -0.18
- Stochastic Oscillator
- PLPC 75.31
- ANAB 5.58
About PLPC Preformed Line Products Company
Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).